which has an estimated incidence and mortality of 8.3 and 8 per 100 000, numbers that likely underestimate the actual problem. 6 A bias likely exists due to multiple factors, including the differential availability of country-specific cancer registries, access to care, and diagnostic modalities, such as upper endoscopy and pathology services. 6, 7 Rwanda is a small country in East Africa with a population of 11.9 million. As of 2016, there were 45 hospitals in Rwanda, comprised of 42 district hospitals, two provincial referral hospitals with university affiliations, and one tertiary care hospital in the capital city, Kigali. There are profound deficiencies that exist in surgical and endoscopy infrastructure, personnel and training within Rwanda, with only 1.2 operating theaters per 100 000 persons and only 1.5 general surgeons per million persons, numbers well below the recommended international minimum of 20 surgical, anesthesia, and obstetric providers per 100 000 persons as established by the Lancet Commission for Global Surgery. 8 There are currently a limited number of public facilities in Rwanda where gastric cancer operations are capable of being performed. Diagnostic delays result in advanced disease presentation for patients with gastric cancer in Africa. 6 Poor diagnostic capacity, limited screening, and low treatment rates for patients with H. pylori are among the potential causative factors that further accentuate high gastric cancer rates in East Africa. 9 The current study represents the first attempt to characterize surgical management and outcomes for patients presenting with gastric cancer in Rwanda. The primary aim was to describe surgical management and characteristics of patients undergoing operations for primary gastric adenocarcinoma.
| METHODS

| Study design and variable definitions
This is a retrospective cohort study of all patients with pathologically or surgically confirmed gastric adenocarcinoma treated at three Rwandan 3 | RESULTS
| Study demographics and epidemiology
A total of 229 patients from three hospitals (RMH, CHUB, and BDH) were included in the study. The median age of the study population was 58 years (IQR, 49-65). Half the patients were male (n = 115, 50.2%) with a median symptomatic period of 12 months (IQR, 7.5-24). The most common presenting symptoms were weight loss (n = 53, 23%) and GOO (n = 43, 18.8%); the most common physical examination finding was a palpable abdominal mass (n = 31, 13.5%). Most patients were diagnosed with endoscopy and biopsy (n = 164, 71.6%) and just over one-quarter of patients had a pretreatment CT scan performed (n = 63, 27.5%).
Other demographic and perioperative variables are listed and summarized in Table 1 .
| Treatment and complications for patients with gastric tumors
Just over half of patients underwent any operative procedure (n = 117, 51%; Table 2 Table 3 ).
Among patients undergoing an operation, 31 (13.5%) patients experienced some type of complication. among this population, gastric cancer was identified as the sixth most common solid, nonskin cancer tumor. 17 In 2014, a 1-year observational study at two Rwandan referral hospitals demonstrated that out of 82 total patients with GOO, over two-thirds were diagnosed with gastric cancer. 18 Ntakiyiruta described a retrospective case series of 35 patients with gastric cancer collected over a period of 1 year at Kibogora hospital in Rwanda.
| Tumor pathology and H. pylori testing
More than three-quarters of tumors were considered T3, and pathology results, available in only 57% of cases, revealed intestinal-type gastric adenocarcinoma in all specimens. There was no evaluation of H. pylori infection, nor of alcohol and tobacco consumption. The median time between symptom onset and diagnosis was 12 months in our study. In the case of symptomatic patients or those strongly suspected of having a malignancy, an earlier referral is often inhibited by a lack of providers and lack of financial coverage for cancer treatments, an issue not specific to Rwanda. 22, 23 If a symptomatic patient is not referred to a facility with diagnostic capabilities after presenting to a more remote facility, the patient is unlikely to receive timely medical care.
Delays in referrals result in more advanced disease presentation that can necessitate palliative, rather than curative surgery. In Nigeria, patients with gastric malignancies commonly present with advanced tumors, limiting the use of partial gastrectomy and jejunostomy. 24 Only 37% of patients in our study underwent a distal gastrectomy. Surgeons should perform curative resection whenever possible and should be trained to recognize and perform curative resections in situations where distal gastrectomy and reconstruction are possible, rather than dependence on the palliative bypass.
It remains unclear what the capacity is for evaluating patients presenting with early symptoms of gastric cancer, such as dyspepsia, in Rwanda. Nearly 75% of patients in our study underwent at least one endoscopy. However, only 11% of study participants had H. pylori testing, which highlights a potential area for improvement for patients with symptomatic dyspepsia and, potentially, gastric cancer.
A recently completed study at CHUB reported that over 1000 upper endoscopies were performed in a 12-month period during 2011-2012. Among this study population, there was a 4.5% rate of malignancy. 25 The main indication for gastroscopy was dyspepsia Victor Zaydfudim for his insights and edits provided in the preparation of this manuscript.
| CONCLUSIONS
